• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析液钙浓度对1α-羟维生素D3对血液透析患者骨骼钙流失和甲状旁腺功能亢进的影响。

The effect of dialysate calcium concentration on 1alpha-hydroxyvitamin D3 on skeletal calcium loss and hyperparathyroidism in haemodialysis patients.

作者信息

Winney R J, Tothill P, Robson J S, Abbot S R, Lidgard G P, Cameron E H, Smith M A, Macpherson H N, Strong J A

出版信息

Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:151s-158s. doi: 10.1111/j.1365-2265.1977.tb03376.x.

DOI:10.1111/j.1365-2265.1977.tb03376.x
PMID:606413
Abstract

The response of hyperparathyroidism and skeletal calcium loss in haemodialysis patients to treatment with 1alpha-hydroxyvitamin D3 and a dialysate calcium concentration of 1.375 mmol/l was compared with the response to treatment with a dialysate calcium concentration of 1.375 or 1.75 mmol/l alone over a 6 month period. In patients treated with 1alpha-hydroxyvitamin D3 there was a significant rise in plasma calcium associated with a significant fall in plasma alkaline phosphatase and plasma parathyroid hormone as well as resolution of sub-periosteal erosions. In these patients there was a significant rise in the calcium content of the forearm assessed by neutron activation analysis in comparison to patients treated with a dialysate calcium concentration of 1.75 or 1.375 mmol/l alone. In patients treated with a dialysate calcium concentration of 1.375 or 1.75 mmol/l alone there was no significant change in the plasma calcium, alkaline phosphatase or parathyroid hormone after 6 months and in these patients subperiosteal erosions either did not change or became worse. No significant difference in the response in these two groups was observed. This study indicates that treatment of haemodialysis patients with 1alpha-hydroxyvitamin D3 is significantly more effective than treatment with a dialysate calcium concentration of 1.375 or 1.75 mmol/l alone in preventing progression of hyperparathyroidism and skeletal calcium loss.

摘要

在6个月的时间里,比较了血液透析患者甲状旁腺功能亢进和骨骼钙流失对1α-羟基维生素D3及透析液钙浓度为1.375 mmol/l治疗的反应,与单独使用透析液钙浓度为1.375或1.75 mmol/l治疗的反应。接受1α-羟基维生素D3治疗的患者血浆钙显著升高,同时血浆碱性磷酸酶和血浆甲状旁腺激素显著下降,骨膜下侵蚀也得到缓解。与单独使用透析液钙浓度为1.75或1.375 mmol/l治疗的患者相比,通过中子活化分析评估,这些患者前臂的钙含量显著增加。单独使用透析液钙浓度为1.375或1.75 mmol/l治疗的患者,6个月后血浆钙、碱性磷酸酶或甲状旁腺激素无显著变化,这些患者的骨膜下侵蚀要么没有变化,要么恶化。两组的反应未观察到显著差异。这项研究表明,在预防甲状旁腺功能亢进和骨骼钙流失进展方面,用1α-羟基维生素D3治疗血液透析患者比单独使用透析液钙浓度为1.375或1.75 mmol/l治疗显著更有效。

相似文献

1
The effect of dialysate calcium concentration on 1alpha-hydroxyvitamin D3 on skeletal calcium loss and hyperparathyroidism in haemodialysis patients.透析液钙浓度对1α-羟维生素D3对血液透析患者骨骼钙流失和甲状旁腺功能亢进的影响。
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:151s-158s. doi: 10.1111/j.1365-2265.1977.tb03376.x.
2
The effect of 1alpha-hydroxyvitamin D3 on calcium and mineral content of bone in renal osteodystrophy.1α-羟维生素D3对肾性骨营养不良患者骨骼钙和矿物质含量的影响。
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:131s-138s. doi: 10.1111/j.1365-2265.1977.tb03373.x.
3
Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.静脉注射1-α-羟维生素D3联合氢氧化镁作为单一磷结合剂预防维持性透析患者的甲状旁腺功能亢进。与碳酸钙±氢氧化镁联合使用的随机对照研究。
Nephron. 1992;60(2):154-63. doi: 10.1159/000186732.
4
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
5
Measurement of whole body calcium in chronic renal failure: effects of 1alpha-hydroxyvitamin D3 and parathyroidectomy.慢性肾衰竭患者全身钙含量的测定:1α-羟维生素D3和甲状旁腺切除术的影响
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:139s-145s. doi: 10.1111/j.1365-2265.1977.tb03374.x.
6
1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.1-α-羟基维生素D3衍生物在治疗肾性骨病中的应用:依据及最佳给药方式
Nephron. 1995;71(3):254-83. doi: 10.1159/000188732.
7
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.维持性血液透析患者中FGF23与骨代谢标志物的相关性及时间进程
Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21.
8
High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.持续性非卧床腹膜透析(CAPD)患者使用高正常钙(1.35 mmol/l)透析液:对血浆钙、磷和甲状旁腺激素进行有效且安全的长期控制
Nephrol Dial Transplant. 1996 Aug;11(8):1586-91.
9
Effects of 1alpha-hydroxyvitamin D3 on serum calcium and immunoreactive parathyroid hormone in patients with chronic renal insufficiency.
Int Urol Nephrol. 1978;10(2):153-60. doi: 10.1007/BF02082136.
10
[Evaluation of the treatment efficacy of secondary hyperparathyroidism with oral pulse doses of alphacalcidol].
Pol Arch Med Wewn. 1997 Oct;98(10):358-65.